Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dyslipidemia

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    April 2016
  1. HIGGINS CA, Rees A
    Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
    Curr Opin Lipidol. 2016;27:207-8.
    PubMed     Text format    


  2. STENDER S, Tybjaerg-Hansen A
    Using human genetics to predict the effects and side-effects of drugs.
    Curr Opin Lipidol. 2016;27:105-11.
    PubMed     Text format     Abstract available


  3. GHAZALPOUR A, Cespedes I, Bennett BJ, Allayee H, et al
    Expanding role of gut microbiota in lipid metabolism.
    Curr Opin Lipidol. 2016;27:141-7.
    PubMed     Text format     Abstract available


  4. GAUDET D
    Novel therapies for severe dyslipidemia originating from human genetics.
    Curr Opin Lipidol. 2016;27:112-24.
    PubMed     Text format     Abstract available


    February 2016
  5. FARR S, Taher J, Adeli K
    Central nervous system regulation of intestinal lipid and lipoprotein metabolism.
    Curr Opin Lipidol. 2016;27:1-7.
    PubMed     Text format     Abstract available


    December 2015
  6. BRAHM AJ, Hegele RA
    Combined hyperlipidemia: familial but not (usually) monogenic.
    Curr Opin Lipidol. 2015.
    PubMed     Text format     Abstract available


  7. SIJBRANDS EJ, Nieman K, Budoff MJ
    Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials.
    Curr Opin Lipidol. 2015;26:586-92.
    PubMed     Text format     Abstract available


  8. GRYN SE, Hegele RA
    Novel therapeutics in hypertriglyceridemia.
    Curr Opin Lipidol. 2015;26:484-91.
    PubMed     Text format     Abstract available


  9. WIERZBICKI AS, Watts GF
    The hinterland of familial hypercholesterolaemia: what do we not know?
    Curr Opin Lipidol. 2015;26:475-83.
    PubMed     Text format     Abstract available


    October 2015
  10. BURKHARDT R
    Hyperlipidemia and cardiovascular disease: reinforcement for 'lower is better'.
    Curr Opin Lipidol. 2015;26:468-9.
    PubMed     Text format    


    June 2015
  11. RYAN A, Byrne CD
    Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Curr Opin Lipidol. 2015.
    PubMed     Text format     Abstract available


  12. SJOUKE B, Hovingh GK, Kastelein JJ, Stefanutti C, et al
    Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives.
    Curr Opin Lipidol. 2015;26:200-9.
    PubMed     Text format     Abstract available


  13. YEANG C, Witztum JL, Tsimikas S
    'LDL-C' = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering.
    Curr Opin Lipidol. 2015;26:169-78.
    PubMed     Text format     Abstract available


  14. TAYLOR BA, Thompson PD
    Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
    Curr Opin Lipidol. 2015;26:221-7.
    PubMed     Text format     Abstract available


  15. BRAAMSKAMP MJ, Hutten BA, Wiegman A
    Early initiation of statin treatment in children with familial hypercholesterolaemia.
    Curr Opin Lipidol. 2015;26:236-9.
    PubMed     Text format     Abstract available


  16. REINER Z
    A comparison of European and US guidelines for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2015;26:215-20.
    PubMed     Text format     Abstract available


  17. QURESHI N, Minhas R, Wierzbicki AS
    Prioritizing health outcomes in a limited world: writing lipid guidelines.
    Curr Opin Lipidol. 2015;26:188-94.
    PubMed     Text format     Abstract available


  18. ROBINSON JG
    Statins and diabetes risk: how real is it and what are the mechanisms?
    Curr Opin Lipidol. 2015;26:228-35.
    PubMed     Text format     Abstract available


  19. CHRISTOFFERSEN M, Tybjaerg-Hansen A
    Novel genes in LDL metabolism--a comprehensive overview.
    Curr Opin Lipidol. 2015;26:179-87.
    PubMed     Text format     Abstract available


  20. WATERS DD
    LDL-cholesterol lowering and renal outcomes.
    Curr Opin Lipidol. 2015;26:195-9.
    PubMed     Text format     Abstract available


    April 2015
  21. PEARS R, Griffin M, Futema M, Humphries SE, et al
    Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2015.
    PubMed     Text format     Abstract available


  22. LU H, Daugherty A
    Atherosclerosis: cell biology and lipoproteins.
    Curr Opin Lipidol. 2015;26:152-3.
    PubMed     Text format    


  23. HEGELE RA, Ban MR, Cao H, McIntyre AD, et al
    Targeted next-generation sequencing in monogenic dyslipidemias.
    Curr Opin Lipidol. 2015;26:103-13.
    PubMed     Text format     Abstract available


  24. LANGE LA, Willer CJ, Rich SS
    Recent developments in genome and exome-wide analyses of plasma lipids.
    Curr Opin Lipidol. 2015;26:96-102.
    PubMed     Text format     Abstract available


  25. COLE CB, Nikpay M, McPherson R
    Gene-environment interaction in dyslipidemia.
    Curr Opin Lipidol. 2015;26:133-8.
    PubMed     Text format     Abstract available


    February 2015
  26. SACKS FM
    The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.
    Curr Opin Lipidol. 2015;26:56-63.
    PubMed     Text format     Abstract available


    June 2014
  27. FILIPPOV S, Pinkosky SL, Newton RS
    LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase.
    Curr Opin Lipidol. 2014.
    PubMed     Text format     Abstract available


  28. TALMUD PJ, Futema M, Humphries SE
    The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes.
    Curr Opin Lipidol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: